R‐DHA‐oxaliplatin (R‐DHAOx) versus R‐DHA‐cisplatin (R‐DHAP) regimen in B‐cell lymphoma treatment: A eight‐year trajectory study.
Saved in:
| Title: | R‐DHA‐oxaliplatin (R‐DHAOx) versus R‐DHA‐cisplatin (R‐DHAP) regimen in B‐cell lymphoma treatment: A eight‐year trajectory study. |
|---|---|
| Authors: | Lacout, Carole1 (AUTHOR) Carole.Lacout@chu-angers.fr, Orvain, Corentin1 (AUTHOR), Seegers, Valérie2 (AUTHOR), De Vries, Manon1 (AUTHOR), Mercier, Mélanie1 (AUTHOR), Farhi, Jonathan1 (AUTHOR), Clavert, Aline1 (AUTHOR), Thepot, Sylvain1,3 (AUTHOR), Moles, Marie‐Pierre1 (AUTHOR), Ifrah, Norbert1,3 (AUTHOR), Hunault‐Berger, Mathilde1 (AUTHOR), Tanguy‐Schmidt, Aline1,3 (AUTHOR) |
| Source: | European Journal of Haematology. Aug2020, Vol. 105 Issue 2, p223-230. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
